Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis

Description

In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).

This Product Explainer is supported by CSL Seqirus

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

ECG Cases with Traces

Dr David Yeo

Dr David Yeo

Gallbladder – When Surgery Is Or Is Not Needed

Dr Susannah Graham & Dr Sanjeev Kumar

Dr Susannah Graham & Dr Sanjeev Kumar

Panel Discussion on Adjuvant Hormone Therapy Post Breast Cancer

Dr Peter Lin

Dr Peter Lin

Covid-19 Infection – What We Know Now

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Richard Harvey

expert

Prof Richard Harvey

Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon, Macquarie University, St Vincent's Hospitals, Sydney; Program Head, Rhinology & Skull Base Surgery, Applied Medical Research Center, UNSW; Professor, UNSW, Macquarie University

Date published: 24 October 2023